Skip to main content

Elahere Prices, Coupons, Copay Cards & Patient Assistance

Elahere (mirvetuximab soravtansine) is a member of the miscellaneous antineoplastics drug class and is commonly used for Fallopian Tube Cancer, Ovarian Cancer, and Peritoneal Cancer.

The cost for Elahere (gynx 100 mg/20 mL) intravenous solution is around $7,091 for a supply of 20 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Elahere prices

Intravenous Solution

gynx 100 mg/20 mL

Elahere intravenous solution

 from $7,090.98

for 20 milliliters
Quantity Per unit Price
20 milliliters $354.55 $7,090.98

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Elahere Coupons, Copay Cards and Rebates

Elahere offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Elahere Copay Assistance Program

Eligible commercially insured patients may pay $0 per dose; patients will be enrolled in the program for 12 months.

Applies to:
Elahere
Number of uses:
Per 12 month period

Form more information phone: 833-352-4373 or Visit website

Patient Assistance & Copay Programs for Elahere

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Elahere (mirvetuximab soravtansine-gynx) Injection

More information please phone: 866-316-7263 Visit Website

Provider: ELAHERE Support Services

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 600% of FPL
  3. FDA-approved diagnosis
  4. Must be a US resident
  5. Co‑payment assistance, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Elahere (mirvetuximab soravtansine-gynx) Injection

More information please phone: 833-352-4373 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.